Association between AGT codon 235 polymorphism and variation in serum concentrations of creatinine and urea in Canadian Oji-Cree

Clinical Genetics

Volumn 55, Issue 6, 1999, Pages 438-443

  Hegele, Robert A ^c   Harris, S B ^a   Hartley, A J G ^d   Zinman, B ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d NONE

Author keywords

Cardiovascular risk; Mutation; Nephropathy; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; CREATININE; UREA;

ABORIGINE; ADOLESCENT; ADULT; ARTICLE; CANADA; CODON; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ALLELES; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; ANGIOTENSINOGEN; BLOOD PRESSURE; CANADA; CHILD; CODON; CREATININE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; UREA;

EID: 0032790419     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1999.550607.x     Document Type: Article

References (29)

1. Wilson R, Krefting LH, Sutcliffe P, VanBussel L. Incidence and prevalence of end-stage renal disease among Ontario's James Bay Cree. Can J Public Health 1992: 83: 143-146.
2. Young TK, Kaufert JM, McKenzie JK, Hawkins A, O'Neil J. Excessive burden of end-state renal disease among Canadian Indians: a national survey. Am J Public Health 1989: 79: 756-758.
3. Fine A, Cox D, Bouw M. Higher incidence of peritonitis in native Canadians on continuous ambulatory peritoneal dialysis. Perit Dial Int 1994: 14: 227-230.
4. Dyck RF, Tan L. Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan. Can Med Assoc J 1994: 150: 203-208.
5. Wilson R, Krefting L, Sutcliffe P, Van Bussel L. Native Canadians relocating for renal dialysis: psychosocial and cultural issues. Can Fam Physician 1994: 40: 1934-1941.
6. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D. Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 1997: 100: 814-820.
7. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, Zinman B. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997: 29: 1073-1077.
8. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, Zinman B. -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. J Hum Genet 1998: 43: 37-41.
9. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao J, Logan A, Zinman B. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997: 20: 185-197.
10. World Health Organization (WHO) Expert Committee on Diabetes Mellitus. Second Report. Geneva: WHO Technical Report Series 646, 1980.
11. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979: 28: 1039-1057.
12. SAS Institute Inc. SAS/STAT Guide for Personal Computers, Version 6 Edition. Cary, NC: SAS Institute Inc, 1987.
13. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Carru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992: 71: 169-180.
14. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995: 95: 948-953.
15. Rotimi C, Morrison L, Cooper A, Oyejide C, Effing E, Ladipo M, Osotemheninen O, Ward R. Angiotensinogen gene in human hypertension: lack of an association of the T235 allele among African Americans. Hypertension 1995: 24: 591-594.
16. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel J-M. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994: 93: 1285-1287.
17. Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235 → Thr variant of angiotensinogen gene in severe familial hypertension. Biochem Biophys Res Commun 1993: 197: 833-839.
18. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark A. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994: 330: 1629-1633.
19. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel J-M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997: 99: 1786-1797.
20. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996:45: 1204-1208.
21. Tarnow L. Cambien F, Rossing P, Neilsen FS, Hansen BV, Ricard S, Poirier O, Parving HH. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996: 45: 367-369.
22. Doria A, Onuma T, Gearin G, Freire MB, Warram JH, Krolewski AS. Angiotensinogen polymorphism M235T, hypertension and nephropathy in insulin-dependent diabetes. Hypertension 1996: 27: 1134-1139.
23. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SL, Gibson SP, Khatoon A, MacDonald F, Rowe BR, Dunger DB, Dean JD, Davies SJ, Webber J, Smith PR, Mackin P, Marshall SM, Adu D, Morris PJ, Todd JA, Barnett AH, Boulton AJ, Bain SC. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996: 39: 1108-1114.
24. Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczk W, Ganten D, Ritz E. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant 1996: 11: 1755-1761.
25. Ringel J, Beige J, Kunz R, Distler A, Sharma AM. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997: 40: 193-199.
26. Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1995: 45: 218-222.
27. Gutierrez C, Vendrell J, Pastor R, Llor C, Aguilar C, Broch M, Richart C. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism 1997: 46: 976-980.
28. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 1998: 31: 627-631.
29. Freire MB, Ji L, Onuma T, Orban T, Warram JH, Krolewski AS. Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 1998: 31: 896-899.